Neurol. praxi. 2014;15(6):350-354
Pharmacological profile of pregabaline (Lyrica)
- Neurologická klinika PKN a FZS Univerzity Pardubice
Pregabaline (Lyrica) is a derivative of gamma-amino-butyric acid. It acts on a subunite of a voltage-gated calcium channel, and in this way it modulates an input of calcium into neurons of the central nervous system. Pregabaline is characterized by anticonvulsive, anxiolytic and analgesic effects. Pregabaline does not bind to plasmatic proteins and nearly unchanged is excreted into urine. An advantage of pregabaline is a linearly increasing effect during increasing dosage of drug. The main indication of pregabaline is neuropathic pain. The next indications are partial epileptic seizures, generalized anxiety disorder, lower back pain associated with neuropathic pain. Pregabaline is very well tolerated. Among undesirable adverse events there are dizziness, somnolence, ataxia, oedemas, weight increase. oedemas.
Keywords: voltage gated calcium channels, anticonvulsive and analgesic effects, neuropathic pain, partial epileptic seizures, dizziness,
Published: December 20, 2014 Show citation
References
- Ambler Z. Pregabalin v léčbě neuropatické bolesti. Farmakoterapie 2011; 7[Suppl.1]: 49-52.
- Bednařík J. Farmakoterapie neuropatické bolesti ve světle medicíny založené na důkazech. Bolest 2014; 17(2): 41-46.
- Bockbrader HN, Burger P, Knapp L, Corrigan BW. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. Epilepsia 2011; 52: 248-257.
Go to original source... 
Go to PubMed... - Kumar N, Laferriere A, Zu JCS, Leavitt A, Coderre TJ. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 2010; 113: 552-561. Go to original source... Go to PubMed...
- Mittal M, Pasnoor M, Mummaneni RB, Khan S, McVey A, Saperstein D, Herbelin L, Ridings L, Wang Y, Dimachkie MM, Barohn RJ. Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy. Int J Neurosci 2011; 121: 521-527. Go to original source... Go to PubMed...
- Pulman J, Hemming K, Marson AG. Pregabalin add-on for drug resistant partial epilepsy. Cochrane Database Syst Rev 2014; Mar12,3: CD005612. Go to original source...
- Semel D, Murphy TK, Zlateva G, Cheung R, Emir B. Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Family Practice 2010; 11: 85-97. Go to original source... Go to PubMed...
- Shoji S, Suzuki M, Tomono Y, Bockbrader HN, Matsui S. Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy. Br J Clin Pharmacol 2011; 72: 63-76. Go to original source... Go to PubMed...
- Tarrio EB, Mateos RG, Bayarri EZ, Gómez VL, Párama MP. Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting. Clin Drug Investig 2013; 33: 633-645. Go to original source... Go to PubMed...
- Vinik A, Emir B, Cheung R, Whalen E. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic neuropathy or postherpetic neuralgia treated with pregabalin. Clin Therapeutics 2013; 35(5): 612-623. Go to original source... Go to PubMed...
- Wiffen PJ, Derry S, Moore RA, Aldington D, cole P, Rice AS, Lunn MP, Hamunen K, Naanpaa M, Kalso EA. Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews. Cochrane Database Syst Rev 2013; Nov 11; 11: CD010567. Go to original source... Go to PubMed...
- Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011; 52(4): 826-836. Go to original source... Go to PubMed...
- Zhang SS, Wu Z, Zhang LC, Zhang Z, Chen RP, Huang YH, Chen H. Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: e meta-analysis. Acta Anasestesiol Scand 2014; Oct 19.doi 10.1111/aas.12420. Go to original source... Go to PubMed...